Insider · CIK 0001380710

Davis George Eric

CIK 0001380710 Name as filed on the most recent filing

Filed as Davis George Eric (76)

129 transaction lines · from 76 filings · filed 2007-02-23 to 2026-02-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

129 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2013-05-03 S, Open-market sale Biomarin Pharmaceutical IncBMRN 393,327, disposed Open Form 4 filing 0001140361-13-019269
2013-03-04 S, Open-market sale Biomarin Pharmaceutical IncBMRN 240,724, disposed Open Form 4 filing 0001140361-13-011089
2013-02-27 S, Open-market sale Biomarin Pharmaceutical IncBMRN 455,186, disposed Open Form 4 filing 0001140361-13-009870
2012-11-19 S, Open-market sale Biomarin Pharmaceutical IncBMRN 357,106, disposed Open Form 4 filing 0001140361-12-048120
2012-11-12 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 562,998, disposed Open Form 4 filing 0001140361-12-047418
2012-11-09 S, Open-market sale Biomarin Pharmaceutical IncBMRN 3 lines 4,237,296, disposed Open Form 4 filing 0001140361-12-047418
2012-05-11 S, Open-market sale Biomarin Pharmaceutical IncBMRN 3 lines 1,604,029, disposed Open Form 4 filing 0001140361-12-025607
2011-11-01 S, Open-market sale Biomarin Pharmaceutical IncBMRN 8,641, disposed Open Form 4 filing 0001140361-11-051506
2011-07-29 S, Open-market sale Biomarin Pharmaceutical IncBMRN 117,800, disposed Open Form 4 filing 0001140361-11-038925
2011-07-22 S, Open-market sale Biomarin Pharmaceutical IncBMRN 115,900, disposed Open Form 4 filing 0001140361-11-037820
2011-05-31 S, Open-market sale Biomarin Pharmaceutical IncBMRN 108,300, disposed Open Form 4 filing 0001140361-11-031045
2011-05-26 S, Open-market sale Biomarin Pharmaceutical IncBMRN 104,500, disposed Open Form 4 filing 0001140361-11-030494
2011-05-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 41,452, disposed Open Form 4 filing 0001140361-11-024864
2011-04-13 S, Open-market sale Biomarin Pharmaceutical IncBMRN 100,700, disposed Open Form 4 filing 0001140361-11-022265
2011-03-09 S, Open-market sale Biomarin Pharmaceutical IncBMRN 146,966, disposed Open Form 4 filing 0001140361-11-016132
2010-11-24 S, Open-market sale Biomarin Pharmaceutical IncBMRN 137,504, disposed Open Form 4 filing 0001140361-10-047230
2010-11-04 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 267,921, disposed Open Form 4 filing 0001140361-10-044040
2010-11-04 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 267,921, disposed Open Form 4 filing 0001140361-10-043950
2010-08-20 S, Open-market sale Biomarin Pharmaceutical IncBMRN 2 lines 322,049, disposed Open Form 4 filing 0001140361-10-034785
2009-12-02 S, Open-market sale Biomarin Pharmaceutical IncBMRN 362,250, disposed Open Form 4 filing 0001048477-09-000110
2009-06-11 S, Open-market sale Biomarin Pharmaceutical IncBMRN 36,175, disposed Open Form 4 filing 0001048477-09-000088
2008-12-04 S, Open-market sale Biomarin Pharmaceutical IncBMRN 114,079, disposed Open Form 4 filing 0001048477-08-000231
2008-10-31 P, Open-market purchase Biomarin Pharmaceutical IncBMRN 2,484, acquired Open Form 4 filing 0001048477-08-000231
2008-07-15 S, Open-market sale Biomarin Pharmaceutical IncBMRN 140,000, disposed Open Form 4 filing 0001048477-08-000190
2008-05-13 S, Open-market sale Biomarin Pharmaceutical IncBMRN 5 lines 391,252, disposed Open Form 4 filing 0001048477-08-000105
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 4 lines 14,693, disposed Open Form 4 filing 0001048477-08-000095
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 18,165, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 14,198, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 10,944, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 10,887, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 10,809, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 7,314, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 7,282, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 7,280, disposed Open Form 4 filing 0001048477-08-000094
2008-04-30 S, Open-market sale Biomarin Pharmaceutical IncBMRN 7,272, disposed Open Form 4 filing 0001048477-08-000094

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 125
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Davis George Eric, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001380710

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.